Beyond the Result Ep 8: Expanding Diagnostic Stewardship Beyond the Hospital

In this episode of Diasorin’s Beyond the Result podcast, host Angelo Rago explores how expanding diagnostic stewardship beyond the hospital can strengthen care delivery across urgent care, retail clinics, long-term care, and other decentralized settings. He is joined by Dr. Donna Wolk, a nationally recognized leader in clinical and molecular microbiology.Highlights include:• How shifting infectious disease testing outside the hospital creates gaps in oversight, protocol consistency, and access to advanced diagnostics, and why stewardship must evolve to meet this shift.• The role of rapid, CLIA‑waived molecular point-of-care technologies in empowering frontline clinicians with timely, actionable results.• Barriers to adoption in alternative care settings, including workflow complexity, reimbursement uncertainty, and variable quality standards.• How connecting decentralized sites into a broader, data‑driven ecosystem can improve antibiotic prescribing accuracy and patient outcomes across the full care continuum.Credits: Host – Angelo Rago, President of Luminex division of Diasorin Guest – Dr. Donna Wolk, MHA, PhD,D(ABMM), Division Chief, Molecular and Microbial Diagnostics and Development Director - Stephanie Ibbotson, Sr. Director of Strategic Marketing and Market AccessProducers – Michelle Tabb, PhD, Chief Scientific Officer and Laura Abelkis, Sr. Planning Manager, Strategic Marketing Editors – Britta Good, Graphic Designer, Global Marketing and Molly Frazier, Brand and Content Marketing Manager Learn about our diagnostics portfolio on our website: https://us.diasorin.com/en/molecular-diagnostics?utm_source=YouTube&utm_medium=YT-description&utm_campaign=Podcast&utm_id=Corporate&utm_term=Ep8